CANCER CELL INT 潤(rùn)色咨詢

Cancer Cell International

出版年份:2001 年文章數(shù):2336 投稿命中率: 開通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:Irregular 自引率:1.6% 審稿周期: 開通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
2633.8元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為67.30%)
自引率
1.6 %
年文章數(shù)
2336
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):14372)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):14163次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):2941次)
期刊簡(jiǎn)介
稿件收錄要求

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

The journal focuses on cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.

Cancer Cell International also considers manuscripts reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, Cancer Cell International is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.

As an established journal, Cancer Cell International publishes many interesting articles from all over the world. It serves a particular need where wide communication of data is required, especially from countries that have a lower profile than many Western countries in biomedical publishing.